MedTrace Logo

Diagnostic Imaging of Myeloma Bone Lesions

NCT03147326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2017-05-10

No results posted yet for this study

Summary

The purpose of this study is to compare the current standard whole-body x-ray with the advanced imaging techniques FDG-PET-CT, NaF-PET-CT and whole-body MRI in the detection of myeloma bone lesions.

Conditions

Interventions

DIAGNOSTIC_TEST

FDG-PET-CT

scanning method

DIAGNOSTIC_TEST

NaF-PET-CT

scanning method

DIAGNOSTIC_TEST

Whole-body MRI

scanning method

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Henrik S. Thomsen, Professor · Department of Radiology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-09-30
Completion
2017-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147326 on ClinicalTrials.gov